Month: September 2026

Providing universal access for developers, the card installs in a desktop, workstation, industrial PC or single-board computer

LAGUNA HILLS, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) — BrainChip Holdings Ltd. (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY), a global leader in ultra-low power, fully digital, event-based neuromorphic AI, announced the AKD1500 PCIe development card, an ultra-low power PCIe card with self-learning capability that delivers silicon evaluation to any desktop or industrial PC.

Built on BrainChip’s AKD1500 Edge AI Co-Processor, the AKD1500 PCIe card installs in a standard PCIe slot in a desktop, workstation, industrial PC or single-board computer, and runs models built in existing frameworks. It is available for purchase now through BrainChip’s online store.

The launch means BrainChip’s AKD1500 chip is available in every form an engineering team needs to build and test edge AI applications: an evaluation card, a deployable M.2 module, packaged/unpackaged silicon and intellectual property (IP) a chip team can license.

It also means Akida can sit in a server anywhere and be tested as part of a team’s development pipeline. Any developer with a PC can now validate Akida with their own models using their own streaming data; a model validated on the card runs on the deployed hardware without change.

“Our customers no longer have to choose between proving out neuromorphic AI and productizing it,” said Sean Hehir, CEO of BrainChip. “Akida is available in every form they need — from card to IP —turning a technology into a complete roadmap for adoption.”

Universal Access Is the BrainChip Advantage

From a low-cost PCIe developer card to M.2 modules, NICLA/Arduino boards, silicon, die and Akida IP cores for custom ASICs, BrainChip’s complete product line puts neuromorphic computing within reach at every stage.

“The first challenge in evaluating new AI architectures is getting your hands on silicon and tools,” said Steve Brightfield, chief product officer of BrainChip. “If you have a PC with a spare slot, you can be running your own models on Akida this afternoon — and what you execute on that card seamlessly carries through to a module, a chip or IP in your own SoC design. The line of adoption is complete.”

BrainChip’s completion of universal access is well-timed given the increase in the number of edge devices incorporating edge AI silicon, such as industrial sensors, cameras, robots and wearables.

ABi Research’s 2Q 2026 market update estimates the edge AI chipset market at $34.4 billion in 2026, growing to $96 billion by 2031, with unit shipments more than doubling from 711 million to 1.59 billion.

Edge devices demand intelligence that runs on a fraction of a watt without a fan or a cloud connection, and they must keep learning once deployed. That is precisely the class of design for which Akida was built; now every team building one can validate it themselves.

The AKD1500 PCIe card launch builds on BrainChip’s industry-leading momentum, which includes production of the AKD1500 chip and launch of the M.2 module over the past two months.

The AKD1500 PCIe card is available for purchase through BrainChip’s online store, with open tools and model library without subscription or license fees.

About BrainChip Holdings Ltd.

BrainChip is the worldwide leader in edge AI on-chip processing and learning. The company’s first-to-market, fully digital, event-based AI processor, Akida™, uses neuromorphic principles to analyze only essential sensor inputs at the point of acquisition, processing data with unmatched efficiency, precision and energy economy. BrainChip’s technology is deployed across industries including aerospace, defense, industrial IoT, healthcare, consumer devices, and wearables. Explore more at www.brainchip.com.

Follow BrainChip:

X: https://www.twitter.com/BrainChip_inc 

LinkedIn: https://www.linkedin.com/company/7792006 

Investor Contact

IR@brainchip.com 

BrainChip Media Contact

Maddie Coe

PRforBrainchip@bospar.com

CRC Sharpens Its Focus on California

LONG BEACH, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) — California Resources Corporation (NYSE: CRC) today announced the signing of an agreement to divest its Uinta Basin assets to an undisclosed buyer for total cash consideration of approximately $90 million, subject to customary purchase price adjustments. The transaction further aligns CRC’s portfolio with its California operations and captures additional value from non-core assets acquired through the Berry merger. CRC expects to use the net proceeds for shareholder returns and other corporate purposes.

“Today’s transaction strengthens our business. The monetization of our Uinta Basin assets sharpens our focus on California and captures additional value from the Berry merger,” said Francisco Leon, CRC President and Chief Executive Officer. “This transaction enhances our capital allocation flexibility, allowing us to invest in higher-return opportunities within the Golden State and supports our shareholder return strategy. The sale also helps offset the purchase price of our recent midstream transaction.”

The transaction has an effective date of July 1, 2026. Closing is subject to the receipt of certain third-party consents and other customary conditions, and is expected by year end. Following the closing of the transaction, CRC expects to provide additional financial and operating guidance.

Advisor

RBC Capital Markets served as financial advisor to CRC.

About California Resources Corporation

California Resources Corporation (CRC) is an independent energy and carbon management company advancing the energy transition. CRC is committed to environmental stewardship while safely providing local, responsibly sourced energy. CRC is also focused on maximizing the value of its land, mineral ownership, and energy expertise for decarbonization by developing CCS and other emissions reducing projects. For more information about CRC, please visit crc.com.

Forward-Looking Statements

Information set forth in this communication, including financial estimates and statements as to the effects of the Berry merger and the Uinta divestiture, constitute “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other securities laws. All statements other than historical facts are forward-looking statements, and include statements regarding the benefits of the Berry merger and the Uinta divestiture, CRC’s future financial position, business strategy, projected revenues, earnings, costs, capital expenditures and plans and objectives and intentions of management for the future. Words such as “expect,” “could,” “may,” “anticipate,” “intend,” “plan,” “ability,” “believe,” “seek,” “see,” “will,” “would,” “estimate,” “forecast,” “target,” “guidance,” “outlook,” “opportunity” or “strategy” or similar expressions are generally intended to identify forward-looking statements. These forward-looking statements are based upon the current beliefs and expectations of the management of CRC and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in, projected in, or implied by, such statements.

Although CRC believes the expectations and forecasts reflected in its forward-looking statements are reasonable, they are inherently subject to numerous risks and uncertainties, most of which are difficult to predict and many of which are beyond its control. No assurance can be given that such forward-looking statements will be correct or achieved or that the assumptions are accurate or will not change over time. Particular uncertainties that could cause CRC’s actual results to be materially different than those expressed in its forward-looking statements are described in its most recent Annual Report on Form 10-K and its other periodic filings with the SEC. These factors include, but are not limited to: fluctuations in commodity prices; production levels and/or pricing by OPEC, OPEC+ or U.S. producers; government policy, war and political conditions and events; integration efforts and projected synergies and other benefits in connection with the Berry merger, the Uinta divestiture and other acquisitions, divestitures and joint ventures; regulatory actions and changes that affect the oil and gas industry generally and us in particular; the efforts of activists to delay or prevent oil and gas activities or the development of CRC’s carbon management segment; changes in business strategy and the ability and financial resources to execute our capital plan in a timely manner; lower-than-expected production; changes to estimates of reserves and related future cash flows; the recoverability of resources and unexpected geologic conditions; general economic conditions and trends; results from operations and competition in the industries in which it operates; CRC’s ability to realize the anticipated benefits from prior or future efforts to reduce costs; environmental risks and liability; the benefits contemplated by its energy transition strategies and initiatives; CRC’s ability to successfully identify, develop and finance carbon capture and storage projects, power projects and other renewable energy efforts; future dividends and share repurchases and de-leveraging efforts; and natural disasters, accidents, mechanical failures, power outages, labor difficulties, cybersecurity breaches or attacks or other catastrophic events.

CRC cautions you not to place undue reliance on forward-looking statements contained in this document, which speak only as of the date hereof, and CRC is under no obligation, and expressly disclaims any obligation to update, alter or otherwise revise any forward-looking statements, whether as a result of new information, future events or otherwise. This communication may also contain information from third-party sources. This data may involve a number of assumptions and limitations, and CRC has not independently verified them and does not warrant the accuracy or completeness of such third-party information.

Contacts:

Daniel Juck (Investor Relations) 818-661-3700 CRC_IR@crc.com

Hailey Bonus (Media) 714-874-7732 CRC.Communications@crc.com

DENVER, Sept. 17, 2026 (GLOBE NEWSWIRE) — (247marketnews.com) — NeOnc Technologies (NASDAQ: NTHI) just removed a potentially significant overhang from its capital structure, redeeming all 6,000 outstanding shares of Series A Convertible Preferred Stock for $6 million in cash, with zero common shares issued in the process.

The move comes only days after NeOnc announced a $15 million registered direct offering, creating a notable one-two punch: fresh capital for the clinical-stage biotech while simultaneously eliminating a preferred security that could have converted into common stock at a substantial discount. The company said the financing was specifically structured to support the redemption.

“We made a deliberate decision to redeem the Series A Preferred Stock in cash and eliminate the potential dilution these securities represented for our shareholders,” CEO and Executive Chairman Amir F. Heshmatpour said.

The timing is particularly notable because the preferred stock’s conversion terms could have become more consequential. Issued in June for $5 million in gross proceeds, the Series A shares carried a four-month cash-redemption window. Had NeOnc not redeemed them, the stated value would have increased and holders could have elected to convert into common stock at 80% of the lowest closing price during the preceding five trading days, subject to a $1 floor.

Instead, NeOnc has effectively shut that door.

The company isn’t making the capital-structure cleanup in isolation. NeOnc is entering the next phase of its CNS cancer story with two clinical programs moving forward. NEO100 recently delivered topline Phase 2a results in recurrent IDH1-mutant high-grade glioma, with the company reporting six-month progression-free survival of 48.9% versus a prespecified 20% benchmark and median overall survival of 26.09 months.

Meanwhile, NEO212 has completed Phase 1 dose escalation, established a recommended Phase 2 dose of 610 mg, and received UAE IND authorization as NeOnc expands its international development pathway.

That puts the latest preferred-stock redemption into a larger narrative: NeOnc is attempting to simplify its capitalization while pushing its drug pipeline toward increasingly important clinical and regulatory milestones.

“We are focused on translating clinical progress into lasting value for patients and shareholders,” Heshmatpour said.

NEO100 and NEO212 remain investigational programs, but the capital-structure move is clear: NeOnc chose to eliminate a potential source of discounted-share conversion before it became available.

For investors watching NeOnc, the story is therefore shifting from simply raising money to how efficiently that capital can be deployed against an advancing CNS oncology pipeline, with one potentially dilutive security now off the table.

About 24/7 Market News

In today’s fast-moving markets, visibility is everything and 24/7 Market News (24/7) provides a powerful suite of investor relations and public relations solutions designed to elevate your company’s profile quickly and effectively. Whether you’re an established name seeking broader awareness, or a micro-cap looking to break out of obscurity, 24/7 delivers targeted, high-impact coverage through timely news distribution, analyst report placements, featured editorials, and multi-channel amplification across financial platforms, social media, and investor communities. Our services help cut through the noise, attract institutional interest, drive exposure, and build long-term shareholder credibility, all while maintaining full SEC compliance and transparency. For Analyst Report coverage, custom IR campaigns, press release syndication, or other tailored investor and public relations solutions, contact sales@247mnn.com to discuss how 24/7 can help accelerate your company’s visibility and valuation trajectory.

This is a paid editorial communication intended for informational purposes only. 24/7 is compensated by NTHI to provide ongoing news coverage of expected upcoming catalysts and events as well as market outreach services. For further disclosure information, please click here. This should not be construed as financial or investment advice. Trading involves substantial risk; consult your financial advisor.

Important Editorial Note: 247 highlights companies approaching significant catalysts and inflection points. This report reflects information available at the time of publication. Since developments can occur rapidly, readers should independently verify current information and review all company filings and disclosures.

CONTACT:
24/7 Market News
Editor@247mnn.com

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company’s ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company’s ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company’s filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.